GLP-1 Metabolic Protocol
GLP-1 receptor agonist protocols evaluated by independent licensed providers. Availability varies by state, program, and clinical appropriateness. State routing configured for intake in select states.
Three Steps to Clinical Intake
The ForgeVita platform routes your intake to an independent licensed clinical practice in your state. Here's what to expect.
Start Assessment
Complete your 5-minute health intake at no cost. Your state is verified for routing availability before any clinical workflow begins.
Clinical Matching
The secure clinical partner workflow discloses the independent provider entity, applicable consents, and all charges before your evaluation begins.
Receive If Prescribed
If treatment is clinically approved by the independent provider, the pharmacy partner fulfills and ships your medication in plain, unbranded packaging.
What Are GLP-1 Receptor Agonists?
Clinical context for patients researching semaglutide and tirzepatide.
GLP-1 receptor agonists are a class of medications that mimic the glucagon-like peptide-1 hormone, which plays a central role in regulating appetite, insulin secretion, and gastric emptying. By activating GLP-1 receptors, these agents promote satiety signals and reduce caloric intake at a physiological level.
Originally developed for the management of type 2 diabetes, GLP-1 agonists have demonstrated meaningful support for sustainable weight reduction in clinically indicated patients across multiple large-scale trials. They are not appetite suppressants in the traditional sense — they work at a hormonal signaling level.
Common agents in this class include semaglutide (marketed as Ozempic for diabetes and Wegovy for weight management) and tirzepatide (marketed as Mounjaro for diabetes and Zepbound for weight management), a dual GIP/GLP-1 receptor agonist. Both require subcutaneous injection on a weekly schedule with gradual dose titration.
All protocols require a valid prescription issued by an independent licensed provider following clinical evaluation. ForgeVita does not prescribe, evaluate, or practice medicine. Clinical services are provided exclusively by independent licensed medical practices.
Important Clinical Considerations
Understanding these factors helps set realistic expectations before beginning the intake process.
Prescription Only
GLP-1 medications require a valid prescription from an independent licensed provider following comprehensive clinical evaluation. They cannot be dispensed without one.
Takes Time
Results typically emerge over weeks to months with gradual dose titration. Dose escalation schedules vary by medication and provider judgment. Individual outcomes vary significantly.
Side Effects Common
Nausea, vomiting, diarrhea, and GI discomfort are commonly reported, particularly during titration periods. Discuss your full medical history and all potential risks with your provider.
Provider Follow-Up
Ongoing provider review is typically required as part of the program. Follow-up cadence, terms, and associated charges are fully disclosed within the secure clinical partner workflow.
Frequently Asked Questions
Transparency about how the platform works, what it costs, and what to expect.
How does the assessment work?
How much does treatment cost?
What medications are available?
Is this covered by insurance?
What if the provider declines to prescribe?
Which states is this available in?
Explore Other Programs
Additional clinical protocols available through the ForgeVita platform.
Ready to Begin Your Assessment?
Complete the 5-minute intake. State availability is verified during the process. No payment required to start.
Start Assessment